Stephen L. Eck - 15 Feb 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Employee stock option (right to buy)	Award	$0	+200,000		$0.000000	200,000	15 Feb 2023	Common Stock	200,000	$4.82	Direct	F1
transaction	MGNX	Restricted Stock Unit	Award	$0	+50,000		$0.000000	50,000	15 Feb 2023	Common Stock	50,000	$0.000000	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F2	Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
F3	The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.